Alkemi helps MedTech companies build the evidence, reimbursement and payer engagement strategies needed to move medical devices, diagnostics, and digital health solutions from innovation to successful market access in target markets worldwide.
.avif)
For MedTech innovators, creating breakthrough devices, diagnostics, and digital health solutions is only half the battle. The next challenge is reimbursement: proving value to payers and healthcare systems so your technology can be adopted at scale.
Alkemi helps MedTech companies tackle the toughest reimbursement challenges and barriers to access. Here’s how.
Clear value stories that translate technical documentation and safety data into relevant outcomes for decision makers
Reimbursement strategies that accelerate coding, coverage, and payment decisions
Negotiation support to strengthen your position with payers, guidelines and value analysis committees
For MedTech innovators, creating breakthrough devices, diagnostics, and digital health solutions is only half the battle. The next challenge is reimbursement: proving value to payers and healthcare systems so your technology can be adopted at scale.
Alkemi helps MedTech companies tackle the toughest reimbursement challenges and barriers to access. Here’s how.
Major change in clinical practice or care delivery required
Technology isn't favorably positioned in clinical guidelines
Low market awareness of unmet need
Reimbursement pathway is insufficient
Technology is expensive and it's unclear why payers should cover it
Policy is supportive of status quo (which doesn't include your technology)
Alkemi partners with MedTech and diagnostics companies to design and execute market access, evidence, and health-economic strategies across the full product lifecycle. From early clinical development through post-market expansion, we help you anticipate access barriers, navigate complex decision ecosystems, and build the evidence and positioning needed to drive adoption.
Whether you’re:
Preparing for launch and building the economic and clinical case for rapid uptake
Coordinating access strategies across priority markets and care settings
Navigating payer processes, coding/coverage/payment pathways, and price negotiations
Demonstrating real-world value to health systems, clinicians, and procurement teams
The strongest MedTech launches start long before market entry. Launch Shield™ identifies what payers, policy makers and providers will need to see, shapes evidence development to match reimbursement requirements, and develops engagement strategies to enable adoption. By the time you reach launch, every key aspect — from coding to coverage to guidelines and payment — is already in place.
Starting at
$150k
When a MedTech product is stalled in the reimbursement process, every day is lost revenue. Alkemi’s Access Threat Response System™ helps market access teams identify evidence that matters, rebuild payer confidence, and remove obstacles to adoption in 90 days or less.
Starting at
$100k
We transform technical data, clinical trial outputs, and real-world evidence into clear value arguments that healthcare providers and payers recognize. This strengthens reimbursement submissions and supports long-term adoption.
Your plan isn't based purely in theory. It's informed by real-world pricing strategies, coverage policies, and reimbursement policies tailored to local regulations, regulatory requirements, and competitive landscapes. Every aspect of the plan is built to secure reimbursement and accelerate patient access.
We understand that the needs of medtech and diagnostics biotech companies are unique. Unlike Pharma companies, regulatory approval comes before you have robust clinical evidence in place and competitive technologies are evolving every few months. Medtech companies need to defend market share, demonstrate real-world value, and show return on investment to maintain commercial success.
Our solutions are customized to the unique challenges medtech companies face.
From the development stage and regulatory clearance through commercialization, Alkemi equips MedTech clients with tools to navigate the policy environment, anticipate competitive threats, and respond to reimbursement challenges in a complex landscape.
MedTech innovators call Alkemi when reimbursement is the deciding factor between adoption and failure because we have years of experience supporting device launches across global healthcare systems.
We specialize in bringing breakthrough MedTech solutions to market, and we do it fast.
Our team delivers reimbursement strategies in as little as 90 days. With us, you can align internal teams and equip leaders with decision-ready evidence in a fraction of the time our industry considers standard.
If you’re facing coverage or payment hurdles, being delayed by inconsistent policies, or facing guidelines pushback, Alkemi can help.
Our focus is simple: get your technology reimbursed and adopted, worldwide.
“Their strategic insights and support were essential – they have a knack for communicating differentiated value.”
![image of successful businesses [headshot]](https://cdn.prod.website-files.com/68c86636bce64aae0bd583b2/68c86c59ad68004ea9ddd6b4_c1cd2a51-1f06-45cb-9a13-4199a77f0015.avif)
"When I presented the project output to our leadership, they said: 'You took a really scary situation and broke it down in terms we understand. It sounds like the team has a clear plan going forward'. That was my goal for this project so sounds like we achieved it."
![[headshot]](https://cdn.prod.website-files.com/68c86636bce64aae0bd583b2/68c86c59dcf34a6442165770_122204b6-f407-479f-9bb7-84c323ad8f65.avif)
"Really appreciate your support - I rang you in a bit of a panic a few weeks ago, yet the session came across as though you’d been working on it for months. Thank you so much - this is an important event for our team, companies and clients - and you really helped make it a success. I heard 3 groups leave with ambitions to up their game - so the message landed as well."
![[headshot] image of customer (for a home inspector)](https://cdn.prod.website-files.com/68c86636bce64aae0bd583b2/68c86c5aee875a9e30534dab_da918c69-68ea-42eb-8ad0-fd4f176193a5.avif)
Thank you very much team! Alkemi has been instrumental in scaling up our research efforts this year.
“Just wanted to send an immediate thank you for the excellent training session today. It was very well received by all of us. What an amazing way to (almost) end the week! Thank you again.”
"Thank you so much to the team for advancing our clinical and HEOR fronts for Innovation!"
"The letter was just submitted. Thank you so much for the excellent work to get this done. Very much appreciated. (LCD Response)"
In MedTech, getting coding, coverage and payment is the make-or-break moment. Without it, even the most promising device, diagnostic, or digital app won’t reach patients or generate revenue.
That’s why Alkemi builds market access and evidence strategies designed to withstand payer questions, policy changes, and provider scrutiny.
We stand behind our work. If your plan doesn’t deliver the traction you need, we refine it with you until it does.
Our market access solutions are designed for the realities of MedTech — whether you’re introducing a diagnostic, launching a device, or scaling a digital health platform.
We map coding, coverage, and payment pathways across healthcare systems to optimize market opportunities and adoption.
We provide data-driven insights into what policy makers, payers, and providers need to see to reimburse and adopt your device compared to alternatives in the competitive landscape.
We align market access, medical and HEOR teams, evidence strategies, and commercial functions around one plan. Then we help you eliminate silos through a dynamic process that keeps your launch on track.
You'll receive arguments, countermeasures, and messaging tested against real payer objections, so your teams know how to respond to public and private payers, policy makers, and other key decision makers in different target markets.
We provide rollout briefs, engagement tactics, and pull-through strategies that make it easier for providers and payers to say yes, ensuring your technology reaches patients faster.
Schedule a Strategy Call with Alkemi and get a partner who understands exactly what your MedTech company needs to achieve reimbursement and expand access. Together, we’ll help you accelerate adoption worldwide.
“Access strategies executed in 90 days instead of 6-12 months, enabling us to act within the critical 30-day decision window, when access positions were still in flux and competitors were unprepared.”
“I wanted to reach out and tell you that the publication is getting GREAT reception from senior BU leadership across the company. Thank you again for your and Alkemi’s support on this project!”
“Stakeholder-validated access arguments built in 42 days, helping us retain Tier 2 formulary status and neutralize a competitor’s evidence positioning before revenue was impacted.”
“Payer value models and communication tools delivered in 45 days, giving our team immediate readiness for coverage discussions, cutting months from pricing and reimbursement timelines.”
"Really appreciate your support - as you know I rang you in a bit of a panic a few weeks ago, yet the session came across as though you’d been working on it for months. Thank you so much - this is an important event for our team, companies and clients - and you really helped make it a success. I heard 3 groups leave with ambitions to up their game - and they’re the 3 that need to do it the most - so the message landed as well."
“Patient access achieved 6 days post-approval, driving a 140% revenue increase and 90% share-price growth within 12 months through a precision-aligned market access plan.”
“Coverage positions worth $100M+ preserved after policy risks were contained and access arguments re-framed within 45 days of the initial threat.”
"When I presented the project output to our leadership, they said: 'You took a really scary situation and broke it down in terms we understand. It sounds like the team has a clear plan going forward'.
“Launch readiness across 7 key markets accelerated by 6 months, improving payer perception, price confidence, and HTA alignment for sustained commercial success.”
“Cross-functional alignment reached in 21 days, uniting medical, HEOR, and commercial stakeholders around payer-critical priorities and evidence generation plans.”
“Research engagement delivered 5X more patients and 6X more clinicians than prior studies, compressing evidence-collection timelines by over 12 months.”
"Thanks to the whole team involved in staging this Advisory Council. I was fortunate to be able to attend and here the insights from the council members firsthand. The report provides an excellent summary."
“Guideline and compendia updates secured within 7 days of approval, converting scientific validation into immediate payer endorsement and market adoption.”